Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.59 |
| ▸ | HPGD | P15428 | 4/20 | 0.59 |
| ▸ | TP53 | P04637 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | CYP2A6 | P11509 | 7/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.52 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.52 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17486128 | 0.96 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2HPGDTP53KDM4E | |
| SCHEMBL22650230 | 0.90 | KMT2A (0.54) | ALDH1A1SMN1; SMN2HPGDTP53KDM4E | |
| SCHEMBL22130016 | 0.90 | CYP2A6 (0.56) | ALDH1A1SMN1; SMN2HPGDTP53KDM4E | |
| SCHEMBL21707244 | 0.86 | CYP2A6 (0.56) | ALDH1A1SMN1; SMN2HPGDTP53KDM4E | |
| SCHEMBL29543568 | 0.84 | SMN1; SMN2 (0.73) | ALDH1A1SMN1; SMN2HPGDTP53KDM4E | |
| SCHEMBL5032444 | 0.84 | SMN1; SMN2 (0.73) | ALDH1A1SMN1; SMN2HPGDTP53KDM4E | |
| SCHEMBL17470582 | 0.83 | CYP2A6 (0.52) | ALDH1A1SMN1; SMN2HPGDTP53KDM4E | |
| SCHEMBL29603965 | 0.83 | CYP2A6 (0.52) | ALDH1A1SMN1; SMN2HPGDTP53KDM4E | |
| SCHEMBL20465274 | 0.83 | MKNK1 (0.53) | ALDH1A1SMN1; SMN2HPGDTP53KDM4E | |
| SCHEMBL24813326 | 0.82 | CYP2A6 (0.60) | ALDH1A1SMN1; SMN2HPGDTP53KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112645893-A | Synthesis method of dihalogenated s-triazine | 营口昌成新材料科技有限公司 | 2021-04-13 | — | — | CN | disclosed |
| US-20210070717-A1 | ORGANIC COMPOUND BASED ON TRIAZINE AND BENZOXAZOLE AND APPLICATION THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE | JIANGSU SUNERA TECHNOLOGY CO., LTD. (CN) | 2021-03-11 | — | — | US | disclosed |
| US-20150249217-A1 | TRIAZINE-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-09-03 | — | — | US | disclosed |
| US-20150249217-A1 | TRIAZINE-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150249217-A1 | TRIAZINE-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | IKZF2, POU5F1, ETV6 | ALDH1A1 564/4885SMN1; SMN2 4769/4885HPGD 3863/4885 |
| US-20210070717-A1 | ORGANIC COMPOUND BASED ON TRIAZINE AND BENZOXAZOLE AND APPLICATION THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE | OCIAD1, EED, OCIAD2 | ALDH1A1 1116/4885SMN1; SMN2 4531/4885HPGD 2216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.